COMMUNIQUÉS West-GlobeNewswire

Where to Buy Testosterone Online 2025 - Top 3 Best Brands of Testosterone Cypionate (Trusted Sites with Testosterone for Sale) - By Testosil

23/04/2025 - 20:28

Las Vegas, April 23, 2025 (GLOBE NEWSWIRE) -- Testosterone is a powerful hormone that is applied to male reproductive and sexual growth . It is used for muscle mass, strength, and endurance also. But as a man grows [...]

Tren Cycle: Trenbolone Steroids Before And After Cycle Results - Legal Tren Steroids For Sale Online from CrazyBulk

23/04/2025 - 20:29

Albany, New York, April 23, 2025 (GLOBE NEWSWIRE) -- Anabolic steroids are carefully formulated chemical substances that serve as important organs in the body. The purpose varies depending on the formulation, with some [...]

Ashwagandha Testosterone Boost: Does Ashwagandha Increase Testosterone? Testosil Supplement Review

23/04/2025 - 20:41

Research suggests that ashwagandha can significantly increase testosterone levels in men. Testosil clinically proven ashwagandha extract boosts testosterone more than exercise alone! Las Vegas, April 23, 2025 (GLOBE [...]

Mitolyn Reviews (Investigative Warning): 2025 Shocking Consumer Reports on Ingredients, Side Effects And Complaints.

23/04/2025 - 21:08

Albany, New York, April 23, 2025 (GLOBE NEWSWIRE) -- In terms of weight loss supplements, actual consumer experiences and real-life outcomes are more significant than promotional exaggeration. As Mitolyn quickly [...]

Colon Broom Reviews: Weight loss,Ingredients - Does Colon Broom Work (UK,Canada/USA)- Consumer Reports & Side Effect

23/04/2025 - 21:24

San Francisco, California, April 23, 2025 (GLOBE NEWSWIRE) -- In a world where every other product tries to be a fiber supplement or detox product, ColonBroom is a great, high-strength formula that does its best to [...]

Sarms Vs Steroids – The Best Sarms And Legal Steroids For Cutting, Bulking And Bodybuilding In 2025 Tested And Rated – By Crazy Bulk.

23/04/2025 - 21:34

New York City, April 23, 2025 (GLOBE NEWSWIRE) -- SARMs are a rather new proposition on the market compared to steroids. An enthusiast of the fitness culture would admit to having heard about SARMs or steroids at some [...]

Best SARMS for Cutting and Bulking to Buy 2025 - Best SARMS for Sale for Muscle Growth, Fat Loss and Bodybuilding- By CrazyBulk

23/04/2025 - 21:45

Albany, New York, April 23, 2025 (GLOBE NEWSWIRE) -- If you’re looking to transform your physique with lean muscle growth, SARMs (Selective Androgen Receptor Modulators) are incredibly popular. Bodybuilders are buying [...]

Mounfit Under Review: Natural Mounjaro Ingredients Recipe to Lose Weight Safely

23/04/2025 - 21:49

Mounfit Offers a Plant-Based, GLP-1 Inspired Weight Loss Supplement as a Natural Alternative to Mounjaro in 2025 Aurora, Colorado, April 23, 2025 (GLOBE NEWSWIRE) -- Introduction Understanding the Modern Weight Loss [...]

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts

23/04/2025 - 22:01

First U.S. patient dosed in ATALANTA-1 study of GLPG5101 Mantle cell lymphoma (MCL), a high-unmet-need hematological malignancy, selected as lead indication for the GLPG5101 program; Pivotal development planned to start [...]

OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025

23/04/2025 - 22:05

WARSAW, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]

RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025

23/04/2025 - 22:05

ALISO VIEJO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]

Sight Sciences Announces the Release of its Sustainability Report

23/04/2025 - 22:05

The Sustainability Report provides data for 2022 through 2024 on the Company’s environmental, social, and governance initiatives MENLO PARK, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT [...]

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

23/04/2025 - 22:05

BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025 [...]

Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients

23/04/2025 - 22:05

The claims cover combination treatment of onvansertib + bev for all bev-naïve patients including RAS-mutated and RAS wild type mCRC across all lines of therapy through 2043 SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- [...]

Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025

23/04/2025 - 22:05

SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies [...]

Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

23/04/2025 - 22:05

WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and [...]

Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025

23/04/2025 - 22:05

NEEDHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies [...]

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

23/04/2025 - 22:05

Year-over-year revenue grows 8% , operating profit up 14% , non-GAAP operating profit up 13% Operating cash flow of $579 million Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at [...]

OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

23/04/2025 - 22:05

BETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2025 financial results and certain business [...]